Zum Inhalt

Lexogen

Lexogen GmbH

Wien,Landstraße
Wien
ÖSTERREICH
Partnerkategorie unternehmerisch tätig

Projektbeteiligungen

Als Partner

RD CLC Screenings

abgeschlossen 2020-2021
Comprehensive Low-Cost Screening Method for SARS-CoV-2 and Respiratory Diseases
1) We develop, produce and provide a novel SARS-CoV-2 test method based on our QuantSeq-Flex (pool) technology and Lx12 indices which is truly mass screening compatible (up to 35˙328 test samples less controls in a single NextSeq run) due to readily available technical capacities but also pricing (ca.…